These include gastrointestinal issues (nausea, vomiting, diarrhea, constipation), pancreatitis, thyroid tumors, gallstones, hair loss, and mental health concerns
That includes both: the GLP-1 your body naturally produces and the medications we now use clinically So menopause may not only reduce estrogenit may also reduce the brains responsiveness to satiety itself
Constipation and diarrhea each affected roughly 10-16% of participants
An eleven-week semaglutide drug dose titration period was started, and during this period, all participants continued using their usual pump therapy
Many new solutions coming to market promise to prescribe GLP-1s